Structure

InChI Key XUFQPHANEAPEMJ-UHFFFAOYSA-N
Smile NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1
InChI
InChI=1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)

Physicochemical Descriptors

Property Name Value
Molecular Formula C8H15N7O2S3
Molecular Weight 337.46
AlogP -0.77
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 7.0
Polar Surface Area 175.83
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 20.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Histamine H2 receptor antagonist DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Gastroesophageal Reflux 4 D005764 ClinicalTrials
Stomach Ulcer 4 D013276 ClinicalTrials
Ulcer 4 D014456 ClinicalTrials
Gastrointestinal Hemorrhage 3 D006471 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Breast Carcinoma In Situ 2 D000071960 ClinicalTrials
Movement Disorders 2 D009069 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Immunoglobulin G4-Related Disease 2 D000077733 ClinicalTrials
Eosinophilic Esophagitis 2 D057765 ClinicalTrials
Schizophrenia 2 D012559 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Thyroid Neoplasms 1 D013964 ClinicalTrials
HIV Infections 1 D015658 ClinicalTrials
Melanoma 1 D008545 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 1 D002289 ClinicalTrials
Fibrosis 1 D005355 ClinicalTrials
Colorectal Neoplasms 1 D015179 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Anemia, Hemolytic, Autoimmune 1 D000744 ClinicalTrials
Psoriasis 1 D011565 ClinicalTrials
HIV Infections 1 D015658 ClinicalTrials

Cross References

Resources Reference
ChEBI 4975
ChEMBL CHEMBL902
DrugBank DB00927
DrugCentral 1129
EPA CompTox DTXSID5023039
FDA SRS 5QZO15J2Z8
Human Metabolome Database HMDB0001919
Guide to Pharmacology 7074
PharmGKB PA449586
SureChEMBL SCHEMBL972
ZINC ZINC000001530636